Don’t invest unless you’re prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more
 

Latest News

Latest news and updates directly from our blog.
bt_bb_section_bottom_section_coverage_image
Dxcover win Life Sciences Company of the Year Award

What a year for Dxcover! Dxcover started the year by closing their bridge series A funding round of £7.5M. They were 1 of just 6 UK winners of the coveted SEIS Grant where they were awarded €2.5M in non-diluted funding. And last week were awarded Life Sciences Company of the Year at the Made in...

Dxcover secures US patent for game-changing cancer diagnostic devices

Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover® Autosampler and the Dxcover® Brain Cancer Liquid Biopsy. The Glasgow-based company has developed an alternative approach to traditional blood sampling liquid biopsy for the early detection of cancer through its unique testing which uses attenuated...

The next stage of development of Afon Technology

As part of the next stage of development of Afon Technology, and in preparation for upcoming clinical trials in Wales, the company moved to a larger, state of the art laboratory facilities. These were formally opened in September and visited by leading Welsh politicians including Peter Fox MS (Member of the Welsh Parliament), Richard John, Leader...

Early brain cancer detection breakthrough for Dxcover

PRESS RELEASE – for immediate release August 2021 DRAFT Early brain cancer detection breakthrough for Dxcover Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival Dxcover acquires all IP for its Dxcover® Liquid Biopsy Technology and Multi Cancer Early Detection (MCED) Platform Early detection of...